Home › Mga Autoimmune na Sakit › Virginia
Pag-aaral pangklinika para sa Mga Autoimmune na Sakit sa Virginia
7 pag-aaral para sa Mga Autoimmune na Sakit ang naghahanap ng mga kalahok sa mga site sa Virginia.
Mga Lungsod sa Virginia
Opisyal na teksto ng pag-aaral (English)
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1009, Charlottesville
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07039916Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- VCU Massey Comprehensive Cancer Center, Richmond
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03816345Study of PTC844 in Participants With Active Rheumatoid Arthritis
- Arthritis & Rheumatism Associates - Fairfax, Fairfax
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07779616A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Virginia Oncology Associates, Norfolk
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Virginia Oncology Associates, Norfolk
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06948318Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis
- Resilient Roots: Functional Medicine, Charlottesville
Nagre-recruit
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07524244A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Virginia, Charlottesville
- Virginia Commonwealth University, Richmond
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.